Bicycle Health Review: Cost, Suboxone Care and Who It Suits

Judged on the part that decides everything: staying in treatment

Bicycle Health treats one condition, opioid use disorder, using buprenorphine and naloxone prescribed by licensed clinicians you meet by video. Self-pay starts at $249 a month, , and the company also bills insurance, so what you actually hand over depends on which door you walk through. The setup works best for someone who wants confidential care without a daily clinic trip, has a private space for video appointments, and accepts drug screening as part of treatment rather than an intrusion. Two trade-offs belong up front: methadone cannot be prescribed by telehealth at all, so anyone who needs it still requires an in-person opioid treatment program, and a recurring subscription means the twelve-month total, not the first charge, is the number that decides affordability. Most Bicycle Health reviews circle four questions, and this one answers them in order: is the company legitimate, what does it cost, how does the clinical care actually run, and what happens when you want out.

What $249 a month buys, and what bills on top

Billing runs as a monthly subscription rather than a charge for each appointment. That entry rate is the lowest recurring self-pay figure a new patient can start on without a longer commitment, and it is the one to carry into any comparison with a local clinic.

The self-pay route

Paying cash keeps the arithmetic clean: one recurring charge for clinical care, no claims to chase, no deductible to clear first. The thing to settle before enrolling is scope. Ask directly whether the fee covers video appointments, messaging with the care team, counseling and drug screening, and whether the pharmacy charge for buprenorphine and naloxone sits inside it or arrives separately from the pharmacy. Generic sublingual film and tablets are widely stocked, and pharmacies price them differently, so the same prescription can land at different totals two blocks apart.

The insurance route

The company bills insurance as well, which rewrites the maths entirely. With a plan, you owe a copay or coinsurance shaped by your deductible instead of the advertised self-pay rate, and in-network status varies by insurer and by state. Two phone calls settle it: ask the provider whether it participates with your plan, then ask your insurer what it pays for virtual opioid use disorder treatment and for the medication. If you are on Medicare, opioid use disorder treatment services including medication and counseling are covered under defined rules, which is worth reading before you assume cash is cheaper (Medicare coverage of opioid use disorder treatment).

Charges that sit outside the subscription

• The medication itself, when the pharmacy bills you directly.
• Laboratory or confirmatory drug testing, when a lab bills separately.
• Any in-person care you still need, including urgent or hospital care.
• Anything unrelated to this condition, such as primary care or dental work.

Do the yearly total before you sign anything, because a subscription that looks small in month one is a four-figure decision across a year.

If you hold insurance and are weighing it against paying cash, compare the two routes side by side rather than guessing which wins.

Rates change, so confirm the figure on the provider’s own site before you enroll. Ours is desk-verified against that site and re-checked monthly, and the weighting behind each dimension is set out in how we score providers.

Buprenorphine and naloxone: the medicine the whole program turns on

How it works

Buprenorphine is a partial opioid agonist. It binds the same receptors as heroin, fentanyl or oxycodone, but activates them less strongly, which flattens withdrawal and cravings without producing the same high. Naloxone is combined with it in the sublingual products to discourage injection. Regulators treat buprenorphine as a first-line medicine for opioid use disorder rather than a last resort (FDA on medication for opioid use disorder), and a Cochrane review of maintenance treatment found it keeps people in care better than placebo (peer-reviewed maintenance review). Retention is the whole game: remaining in treatment is what lowers overdose risk (CDC overdose prevention).

Starting treatment and settling on a dose

Induction is the delicate stretch. Taking buprenorphine too soon after a full agonist can trigger precipitated withdrawal, which comes on fast and feels punishing, so the timing is set by a clinician against your last use and your symptoms. Product labelling describes reaching a maintenance dose through adjustment over the first days, with the prescriber moving it up or down based on cravings, withdrawal signs and side effects (FDA label database). Expect closer contact early and lighter follow-up once you stabilise. Do not adjust your own dose, split it differently or restart after a gap without speaking to the prescriber first, because tolerance falls quickly and a lapse in a gap carries real overdose risk.

Side effects and the warnings that matter

Common effects reported on labelling and patient references include headache, nausea, constipation, sweating, trouble sleeping, and numbness or soreness in the mouth where the film or tablet dissolves (MedlinePlus patient information).

• Dangerous breathing suppression, particularly when combined with benzodiazepines, alcohol, gabapentinoids or other sedating medicines.
• Liver injury, which is why hepatitis status and liver testing come up in intake questions.
• Dental problems including decay and cavities, which the FDA has warned about for buprenorphine medicines dissolved in the mouth; rinsing with water after the dose fully dissolves and keeping up dental care are the standard countermeasures.
• Adrenal insufficiency and low blood pressure on standing, both uncommon but worth reporting.
• Neonatal opioid withdrawal syndrome when used in pregnancy, which does not mean stopping; continuing treatment in pregnancy is usually the safer path and the decision is individual and clinician-led.
• Accidental exposure in children can be fatal, so storage matters as much as dosing.

Who needs a longer conversation before starting

Tell the clinician about benzodiazepine or alcohol use, sleep apnea or other breathing conditions, liver disease or hepatitis C, pregnancy or pregnancy plans, head injury, and every prescription and over-the-counter product you take. None of these automatically rule treatment out, and stopping sedatives abruptly can be more dangerous than the interaction, which is exactly why the disclosure needs to happen in the appointment rather than after the first prescription.

What the medicine does to your monthly outlay

The clinical fee and the pharmacy charge are different bills with different logic. Generic buprenorphine and naloxone has a wide retail spread, and insurance formularies often place it on a low tier for opioid use disorder treatment. Ask which pharmacies the practice routes to, whether a mail pharmacy is available, and what your plan charges for a thirty-day fill, then set that against the subscription rather than treating one figure as the whole cost.

Methadone, naltrexone and where telehealth stops

Methadone for opioid use disorder cannot come from a telehealth subscription. Federal rules restrict it to certified opioid treatment programs with their own dispensing and take-home requirements (42 CFR Part 8). If you have done better on methadone before, or buprenorphine has failed you, a virtual buprenorphine service is the wrong starting point and an in-person program is the right one. That is a limitation of the model, not a criticism of this company.

Extended-release naltrexone is the third FDA-approved option, and it works differently: it blocks opioid effects and requires a period free of opioids before the first injection, which makes it a poor fit for someone still using. Ask this provider directly which medicines its clinicians prescribe and what happens if buprenorphine does not suit you, and note the answer before you pay. National guidance on treatment approaches is a useful primer for that conversation (NIDA treatment approaches). If you are in crisis while sorting any of this out, the national helpline runs free and around the clock (SAMHSA National Helpline).

Counseling, drug screening and peer support in the same app

Behavioral healthcare alongside the prescription

The company describes combining medication for opioid use disorder with behavioral healthcare, drug screening, therapy and peer support through a single app. That bundling matters practically: when counseling sits inside the same service as the prescription, you are not coordinating two providers, two portals and two bills. Ask how often counseling is scheduled, whether it is one to one or group, and whether it is included in the monthly fee or added.

Drug screening as a condition of care, not an extra

Screening is part of controlled-substance prescribing, and treating it as optional misreads the model. Expect to provide samples on a schedule, and expect results to shape how often you are seen. A positive result is not usually an exit from treatment; in good practice it changes the plan, the dose or the follow-up frequency. Ask upfront how the practice handles a positive screen, because that policy tells you more about the clinical culture than any marketing page.

Peer groups

Peer support is the cheapest thing in any recovery program and often the most protective. Where it is included, it costs you time rather than money. Ask about meeting times and formats, since virtual groups scheduled only in working hours are useless to shift workers.

Confirm the exact cadence for each element at intake, since it is set per patient rather than fixed for everyone.

Getting started: intake to first prescription

Step 1: Check the service reaches your state

Clinicians must hold a licence where you are sitting during the appointment, so coverage is a state question even for a national service. Confirm your state before you give payment details.

Step 2: Book the first appointment

The company advertises same-day or next-day telehealth appointments, which is the single most valuable feature in this category. Someone ready to start treatment on a Tuesday morning rarely stays ready until a Thursday next week.

Step 3: Complete the medical intake

Expect questions about your opioid use history, last use, previous treatment attempts, other substances, mental health, pregnancy, and current medicines. Answer the sedative and alcohol questions honestly; the prescriber is managing breathing risk, not judging you.

Step 4: Attend the video visit and agree the plan

Induction timing, the treatment agreement, screening schedule and follow-up frequency are settled here. Ask what happens out of hours and who to contact if withdrawal symptoms hit hard on day one.

Step 5: Prescription, pharmacy and first fill

Ask which pharmacy the prescription is sent to, how long the first fill usually takes, and how refills are requested. Controlled-substance prescriptions have less room for pharmacy mix-ups than a shampoo subscription does, so confirm your pharmacy stocks the product before you leave the appointment.

The app, the login and everyday use

The patient app is listed publicly on Google Play and is described by the company as the place where virtual medication treatment for opioid use disorder runs, which tells you the model is app-first rather than email-and-phone. In practice that means appointment booking, messaging the care team, and access to your treatment plan live in one login. Search interest in the login and app suggests the usual pattern for app-first care: it is smooth when it works and frustrating when a password reset stands between you and a refill request.

Two things to test in the first week. First, whether messages get a reply inside a working day, because messaging is your main contact route. Second, whether appointment reminders actually arrive, since a missed follow-up in controlled-substance care can mean a gap in medication rather than a rescheduled chat.

Cancelling

Cancellation on a subscription is a billing action and a clinical one at the same time. Ask before you enroll how you cancel, whether notice is required before the next billing date, and whether any part-month is refunded. Then ask the clinical question that patients forget: what taper or transfer support exists if you stop the subscription while still on medication. Stopping buprenomorphine abruptly brings withdrawal, so an exit plan is part of a safe exit, not an afterthought. Get a bridge prescription or a referral in writing rather than a verbal promise.

Support, refills and reaching a human

Support quality in this category is measured in one currency: whether your refill arrives before your last dose does. Ask which channels exist for clinical questions, for billing questions, and for urgent problems, and whether any of them is a phone line staffed by a person. Volume of searching for the phone number and the billing phone number suggests plenty of patients want a voice rather than a message thread, so collect those routes at intake and save them in your phone.

On refills, three questions cover most failure points. How far ahead of running out should you request one. What happens if a screening result or a missed appointment holds the refill. Who contacts the pharmacy when a fill is rejected or out of stock. Write the answers down. Continuity is the difference between a bad week and a relapse, and the practical detail sits in these boring logistics rather than in any marketing claim.

If you are weighing several virtual services, our telehealth provider directory is a faster way to line up support models than reading each company’s own pages.

Privacy, records and what covers your treatment notes

Substance use disorder records carry stronger federal protection than ordinary medical notes. Records from federally assisted treatment programs fall under confidentiality rules that limit disclosure without your written consent, including in many legal contexts (42 CFR Part 2). That is the legal floor, and it is a meaningful one if you are worried about an employer, a custody dispute or an insurer.

Consumer app data is a separate matter from clinical records, and the two are governed differently. Before you enroll, read the privacy notice for four specifics: what the app collects beyond your clinical information, whether any analytics or advertising partners receive data, how consent works for sharing records with an employer, court, or another clinician, and how to request deletion of your account data. Ask, too, what appears on any insurance claim if you use the insurance route, since claims travel to the plan holder in some households.

Legitimacy: the certification, the record, and the lawsuit searches

The most common question here is the simplest to answer factually. The service holds LegitScript certification, which is the baseline vetting standard for telehealth and pharmacy businesses handling prescription and controlled-substance care, and which payment processors and ad platforms rely on. You can confirm any company’s status yourself through the certification lookup (LegitScript certification lookup). No FDA warning letter appears against the company in our checks. Its own site presents the service as confidential online Suboxone treatment, and an independent encyclopedia entry records a Boston-founded virtual opioid use disorder provider operating since 2017.

Certification is not a quality rating; it says the business has been vetted against defined standards, not that every patient has a good experience. Buprenorphine is a controlled substance, so a legitimate service will always evaluate you before prescribing, verify your identity and location, require follow-up, and screen. A service promising medication with no appointment and no monitoring would be the warning sign, not this one.

Searches for a lawsuit are common for any venture-backed health company, and they deserve a straight answer rather than a nervous one. Litigation claims belong in court dockets and state medical board records, which are public and searchable; a claim in a forum post is not a finding, and a settled or dismissed case is not proof of harm. If a specific case matters to your decision, look it up in the relevant court’s records and read the outcome rather than the headline.

Who this suits, and who should look elsewhere

This is a strong fit if you want buprenorphine treatment without a waiting room, live far from a clinic, work hours that make in-person visits impossible, need care to stay private, or want counseling and prescribing under one login. It also suits someone stable on buprenorphine already who mainly needs reliable refills and follow-up.

Look elsewhere if you need or want methadone, if you have relapsed repeatedly on buprenorphine and need a higher level of care, if you need medically supervised withdrawal or inpatient treatment, if you have no private space or reliable connection for video appointments, or if you need in-person medical care for other conditions that a single-condition service will not touch. If cost is the deciding factor and you have insurance, an in-network local program can beat any cash subscription; if you have no coverage, a predictable monthly figure often beats unpredictable clinic billing. Our telehealth explainers cover that trade-off across categories, and the medication reference is useful background before your first appointment.

Questions worth asking before your first appointment

• Does the monthly fee include counseling, drug screening and messaging, or are any of those billed separately?
• Is the pharmacy charge for buprenorphine and naloxone inside the fee or paid at the pharmacy?
• Are you in network with my insurance plan in my state, and what will I owe?
• How often will I be seen in the first month, and how often after that?
• What happens to my prescription if a screening result is positive or I miss an appointment?
• How do I cancel, how much notice is needed, and what taper or referral support comes with stopping?

If you are switching from another provider, ask your existing one for a records copy, the exact date your last prescription covers, and written confirmation of when the subscription ends, so you do not pay two services in the same month or run out mid-transfer.

Quick tip: put the twelve-month figure for both payment routes next to each other before you enroll, using Run my numbers, and check the worked example in our free savings report.

Reputation check

Public sentiment here is thinner than in consumer telehealth categories, and that is normal: people rarely post under their own names about opioid use disorder treatment. What is attributable is limited but useful. The company maintains a patient app listed on Google Play, describing digital medication for addiction treatment for opioid use disorder. Its own site positions the service as confidential online Suboxone treatment. An independent encyclopedia entry records it as a Boston-based virtual opioid use disorder provider founded in 2017.

Search behaviour is the clearest signal of what worries prospective patients, and it clusters into four groups: whether the company is legitimate, what it costs each month, how to reach a person by phone for billing or an urgent issue, and litigation claims. The first two are settled by the certification record and the advertised monthly rate. The third is answerable only by collecting the support and billing routes at intake and testing them early. The fourth belongs to court and state board records rather than social threads. Worth noting for anyone reading widely: some Bicycle Health reviews that surface in search are written by employees about working conditions, and they say nothing about the care a patient receives.

Community reviews on our own pages are moderated, incentivised reviews are always labelled, and sponsored placement, where it exists, is labelled and never changes a score or a ranking.

Educational content, not medical advice. Always consult a qualified clinician before starting, stopping or switching treatment.